Skip to main content
News Analysis

Windsor-Essex Issues Back-to-Back Opioid Alerts for the First Time Since 2018: A Practical Guide to Naloxone, Warning Signs, and Getting Help

The Windsor-Essex County Health Unit has issued opioid overdose alerts in consecutive weeks for the first time since its notification system launched, with a veterinary tranquilizer showing up in the local fentanyl supply. Here's practical, non-judgmental guidance on naloxone access, recognizing an overdose, and staying safer in extreme heat.

By Refdesk Team

Windsor-Essex Issues Back-to-Back Opioid Alerts for the First Time Since 2018: A Practical Guide to Naloxone, Warning Signs, and Getting Help

What This Means for You

Public health surveillance data out of Windsor-Essex points to a genuinely unusual event: two consecutive weeks of formal opioid overdose alerts, something the region's notification system has not recorded since it launched in 2018. Whether you use substances yourself, love someone who does, work in a front-line role, or simply live in the region, there are specific, practical steps worth taking right now — not to panic, but because a contaminated drug supply and extreme summer heat are compounding each other in a way that is measurably increasing risk.

If You or Someone You Know Uses Drugs:

Immediate action:

  • Assume any street-sourced opioid is contaminated right now. The Windsor-Essex Community Opioid and Substance Strategy (WECOSS) has identified medetomidine — a veterinary sedative, not an opioid — mixed into local fentanyl supplies. Medetomidine does not respond to naloxone the way opioids do, which means an overdose can look different (deeper sedation, slower recovery) and may require more doses of naloxone plus emergency medical care, not less.
  • Never use alone. Call the National Overdose Response Service (1-888-688-6677), a free, confidential phone line that stays on the line with you while you use and calls for help if you become unresponsive. This is anonymous and available anywhere in Canada, 24/7.
  • Get a free naloxone kit before you need one. Kits are available with no prescription and no health card required at pharmacies across Windsor-Essex and at the Windsor-Essex County Health Unit's Windsor office (1005 Ouellette Ave., 519-258-2146) and Leamington office (33 Princess St., 519-326-5716). Ask specifically for training on recognizing an overdose, since the symptom picture has shifted with medetomidine in the supply.
  • Use fentanyl test strips if available. Test strips can flag the presence of fentanyl in a substance, though they will not detect medetomidine specifically. Local service providers distributing harm-reduction supplies, including Pozitive Pathways Community Services (511 Pelissier St.) and the Welcome Centre Shelter for Women (263 Bridge Ave.), carry test strips and clean supplies.

What to prepare:

  • Learn the medetomidine-adjusted overdose picture. WECOSS program director Eric Nadalin has described symptoms consistent with medetomidine mixed into fentanyl, including deeper and more prolonged sedation than fentanyl alone typically produces. If someone doesn't respond to a first or second dose of naloxone within 2–3 minutes, keep administering additional doses (most kits contain two) and call 911 — do not assume naloxone has failed just because the response is slower than expected.
  • Know that Ontario's Good Samaritan Drug Overdose Act protects you. If you call 911 for an overdose, you and the person who overdosed are protected from simple drug possession charges at that scene, even if you're also using. Fear of arrest should not stop you from calling for help.

Resources:

  • Ontario Naloxone Program kit locator and information: wechu.org/opioids/how-get-naloxone-kit
  • WECOSS resource directory: wecoss.ca/resource
  • National Overdose Response Service: 1-888-688-6677
  • Windsor-Essex County Health Unit: 519-258-2146 (Windsor) / 519-326-5716 (Leamington)

Example scenario: A friend who used what they believed was their usual fentanyl supply becomes unresponsive and doesn't wake up after one dose of naloxone. Based on WECOSS's current alert, the correct response is: call 911 immediately, administer a second dose of naloxone if 2–3 minutes have passed with no response, begin rescue breathing if trained to do so, and stay with the person until paramedics arrive — do not assume the first dose "didn't work" and give up.

If You're a Parent, Employer, or Community Member:

Immediate action:

  • Talk to teens and young adults about counterfeit pills. Fentanyl and, increasingly, medetomidine-adulterated fentanyl show up in pills sold as prescription opioids, benzodiazepines, or even stimulants. A pill that didn't come from a licensed pharmacy carries real risk regardless of what it's sold as.
  • If you manage a workplace, post naloxone kit locations and basic overdose-response information in break rooms and washrooms. WECOSS's "Harm Reduction in the Workplace" guidance (available at wecoss.ca) is designed for exactly this use case and does not require you to make assumptions about which employees might be at risk.

What to prepare:

  • Stock a naloxone kit at home or at work even if you don't think you need one. Bystanders — coworkers, family members, strangers in a parking lot — are frequently the ones who administer the first dose in a real overdose. The kits are free, small, and simple to use with brief training.

For All Canadians:

Why this matters beyond Windsor-Essex: Contaminated drug supplies do not stay geographically contained, and medetomidine has already been detected in illicit opioid supplies in other Canadian and U.S. jurisdictions over the past two years. If you live outside Windsor-Essex, check whether your local public health unit operates a similar alert system — most major Ontario health units do — and bookmark it. The core lesson from this alert generalizes anywhere: heat waves measurably increase overdose risk (through dehydration and altered drug metabolism), so extreme-heat public health warnings and drug-toxicity warnings should be read together, not separately, during summer months.

The News: What Happened

According to CBC News, the Windsor-Essex County Health Unit issued an opioid overdose alert covering June 28 to July 4, 2026, reporting 29 opioid overdoses during that period, 19 of which involved fentanyl. This followed an earlier alert for the preceding week, after the region's Opioid and Substance Use Notification System (OSUNS) flagged six suspected drug-related deaths between June 21 and 27, along with 18 opioid overdose emergency department visits, 17 involving fentanyl, according to CBC News reporting.

CBC News reports that, taken together, the region recorded 47 opioid overdoses and six drug-related deaths between June 21 and July 4 — and that this marked the first time since OSUNS launched in 2018 that alerts have been issued in back-to-back weeks. Windsor News Today and local outlet AM800 CKLW reported an additional spike of 22 substance-use-related EMS calls on June 30 alone.

WECOSS program director Eric Nadalin told local media that symptoms consistent with medetomidine — a veterinary sedative — mixed into the local fentanyl supply have been observed in recent overdose cases, complicating both identification and response. Coordinating agencies named in reporting include the Windsor-Essex County Health Unit, Windsor Regional Hospital, Essex-Windsor EMS, Erie Shores HealthCare, and local police services. Public health officials have also pointed to extreme summer heat as a contributing risk factor, noting that dehydration and heat stress can increase the likelihood and severity of an overdose.

Analysis: Why This Matters

Based on our analysis of overdose alert patterns since Windsor-Essex's notification system launched in 2018, back-to-back weekly alerts represent a meaningful escalation rather than routine fluctuation — this kind of surveillance system is specifically designed to flag statistically unusual clusters, not general baseline activity. The introduction of medetomidine into the local supply is the more significant underlying development. Because medetomidine is not an opioid, it does not fully respond to naloxone, which is the primary tool front-line responders and people who use drugs rely on to reverse an overdose. That gap between "the tool people know how to use" and "what's actually in the supply" is where the practical risk concentrates.

The heat-overdose interaction flagged by health officials also deserves attention beyond this specific alert. Dehydration alters how the body processes and clears opioids, and extreme heat independently strains cardiovascular and respiratory systems — the same systems opioid overdose suppresses. During a summer heat event, these risks compound rather than simply add together.

Historical Context:

Windsor-Essex has operated a formal opioid alert and notification system since 2018, part of a broader wave of Ontario public health units adopting real-time drug-toxicity surveillance following the acceleration of fentanyl contamination in the illicit drug supply starting around 2016. Novel adulterants entering the supply — first fentanyl itself displacing heroin, then benzodiazepine-adulterated fentanyl ("benzo-dope") in several provinces from 2020 onward, and now medetomidine — have repeatedly outpaced the response tools available to front-line workers and health units, requiring repeated public education campaigns each time the supply shifts.

What Happens Next:

  • Near-term: Expect WECOSS and the Health Unit to continue issuing rapid alerts if overdose or death counts remain elevated, and to update public guidance if medetomidine-specific response protocols change.
  • Ongoing through summer: Extreme-heat warnings and drug-toxicity alerts are likely to continue overlapping; watch for combined public health messaging.
  • Longer-term: Provincial and federal drug-checking programs may expand test-strip and supply-testing capacity if medetomidine contamination is confirmed to be spreading beyond Windsor-Essex.

Your Action Plan

Immediate (This Week):

  • If you or someone you know uses drugs, get a free naloxone kit from a Windsor-Essex pharmacy or the Health Unit and ask for a medetomidine-response briefing.
  • Save the National Overdose Response Service number (1-888-688-6677) in your phone.
  • If you're an employer, confirm whether your workplace has a naloxone kit and post its location visibly.

Short-term (This Month):

  • Talk to teens or young adults in your life about counterfeit pill risk, using non-judgmental, fact-based language.
  • Check whether your local public health unit (if outside Windsor-Essex) operates a similar drug-alert system, and bookmark it.

Long-term (This Year):

  • Support or volunteer with local harm-reduction organizations (Pozitive Pathways Community Services, Welcome Centre Shelter for Women) if you're in the Windsor-Essex region.
  • Stay informed on provincial drug-checking and supply-testing program expansions as medetomidine contamination is monitored.

Other Perspectives

Public Health View:

WECOSS program director Eric Nadalin has said overdose symptoms consistent with medetomidine contamination are being observed locally, and has emphasized distributing test strips and harm-reduction supplies through service providers as a front-line response.

Front-Line Service Provider View:

Organizations named in reporting, including Pozitive Pathways Community Services and the Welcome Centre Shelter for Women, continue to operate needle syringe and harm-reduction programs providing naloxone, test strips, and safer-use supplies directly to people who use drugs.

Emergency Response View:

Essex-Windsor EMS and area hospitals, including Windsor Regional Hospital and Erie Shores HealthCare, are named as coordinating partners tracking overdose and EMS call volumes in real time as part of the regional alert system.

Affected Community View:

People who use drugs and their families face the practical consequence of this alert most directly: a drug supply that responds less predictably to the primary overdose-reversal tool available to them, during a period of extreme heat that independently raises risk.

Note: Including multiple perspectives doesn't imply all views are equally valid, but ensures readers can make informed judgments.

Corrections Policy

We strive for accuracy. If you find an error in this analysis, please email us at [email protected]. We will promptly investigate and correct any factual inaccuracies.

Updates:

  • No corrections to date (as of July 10, 2026)

Sources

Get the Daily Canadian Briefing

The news, policy changes, and money moves that matter — delivered to your inbox every morning.

We'll send a confirmation email. No spam, ever.